Literature DB >> 6822662

Deficient adenylate cyclase regulatory protein in renal membranes from a patient with pseudohypoparathyroidism.

R W Downs, M A Levine, M K Drezner, W M Burch, A M Spiegel.   

Abstract

Recent studies have established that some patients with pseudohypoparathyroidism have a deficiency of the adenylate cyclase regulatory protein (the G unit) in plasma membranes from erythrocytes, platelets, and fibroblasts. We have directly measured the activity of the G unit in renal membranes from a patient with pseudohypoparathyroidism who, in addition to parathyroid hormone resistance, has resistance to thyrotropin and gonadotropins. Erythrocyte membrane G unit activity was 57% that of control erythrocyte membranes. Lubrol PX extracts of renal membranes had only 30% of the G unit activity of control renal membrane extracts, whether assayed with sodium fluoride or guanosine-5'-O-(3-thiotriphosphate) (GTP-gamma-S). In cholate extracts, the G unit activity was 37 and 48% of control with fluoride or GTP-gamma-S, respectively. Cholera toxin-dependent incorporation of [32P]ADP-ribose into the 42,000-Mr subunit of the G unit was decreased in renal membranes from the patient compared with control renal membranes. The data demonstrate that the membrane G unit deficiency in pseudohypoparathyroidism extends to the cells of a clinically relevant parathyroid hormone target tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822662      PMCID: PMC436861          DOI: 10.1172/jci110763

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

Authors:  D M Gill; R Meren
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Genetic evidence that cholera toxin substrates are regulatory components of adenylate cyclase.

Authors:  G L Johnson; H R Kaslow; H R Bourne
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

3.  Selection of a variant lymphoma cell deficient in adenylate cyclase.

Authors:  H R Bourne; P Coffino; G M Tomkins
Journal:  Science       Date:  1975-02-28       Impact factor: 47.728

4.  Partial gonadotrophin-resistance in pseudohypoparathyroidism.

Authors:  J I Wolfsdorf; R L Rosenfield; V S Fang; R Kobayashi; A K Razdan; M H Kim
Journal:  Acta Endocrinol (Copenh)       Date:  1978-06

5.  Thyroid dysfunction in pseudohypoparathyroidism.

Authors:  S J Marx; J M Hershman; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

6.  The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro.

Authors:  L R Chase; G D Aurbach
Journal:  J Biol Chem       Date:  1970-04-10       Impact factor: 5.157

7.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin.

Authors:  L R Chase; G D Aurbach
Journal:  Science       Date:  1968-02-02       Impact factor: 47.728

10.  Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone.

Authors:  L R Chase; G L Melson; G D Aurbach
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

View more
  11 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1.

Authors:  Suzanne Jan de Beur; Changlin Ding; Emily Germain-Lee; Justin Cho; Alexander Maret; Michael A Levine
Journal:  Am J Hum Genet       Date:  2003-07-11       Impact factor: 11.025

3.  Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy.

Authors:  M A Levine; T G Ahn; S F Klupt; K D Kaufman; P M Smallwood; H R Bourne; K A Sullivan; C Van Dop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Increase of adenylate cyclase catalytic-unit activity by dexamethasone in rat osteoblast-like cells.

Authors:  R Rizzoli; V von Tscharner; H Fleisch
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

Review 5.  Endocrine control and disturbances of calcium and phosphate metabolism in children.

Authors:  K Kruse
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

6.  Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy.

Authors:  L C Wilson; M E Oude Luttikhuis; P T Clayton; W D Fraser; R C Trembath
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

Review 7.  Albright's hereditary osteodystrophy.

Authors:  L C Wilson; R C Trembath
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

8.  [Pseudohypoparathyroidism and adrenal cortex insufficiency. A case of multiple endocrinopathy due to peripheral hormone resistance].

Authors:  P Ridderskamp; R Schlaghecke
Journal:  Klin Wochenschr       Date:  1990-09-14

9.  Overexpression of stimulatory G protein alpha-subunit is a hallmark of most human somatotrophic pituitary tumours and is associated with resistance to GH-releasing hormone.

Authors:  C Hamacher; M Bröcker; E F Adams; T Lei; R Fahlbusch; M Buchfelder; M Derwahl
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

10.  Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells.

Authors:  M A Levine; C Eil; R W Downs; A M Spiegel
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.